Business Description
Jasper Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US4718712023
Share Class Description:
JSPR: Ordinary SharesDescription
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.71 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -5.9 | |||||
| 3-Year EPS without NRI Growth Rate | -3.7 | |||||
| 3-Year FCF Growth Rate | -1.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 7.19 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.26 | |||||
| 9-Day RSI | 49.04 | |||||
| 14-Day RSI | 51.26 | |||||
| 3-1 Month Momentum % | 20.9 | |||||
| 6-1 Month Momentum % | 2.42 | |||||
| 12-1 Month Momentum % | 380.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.61 | |||||
| Quick Ratio | 7.61 | |||||
| Cash Ratio | 7.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -43.4 | |||||
| Shareholder Yield % | -13.34 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -67.61 | |||||
| ROA % | -58.33 | |||||
| ROIC % | -811.19 | |||||
| 3-Year ROIIC % | -962.41 | |||||
| ROC (Joel Greenblatt) % | -1787.21 | |||||
| ROCE % | -70.24 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.15 | |||||
| Price-to-Tangible-Book | 4 | |||||
| EV-to-EBIT | -3.59 | |||||
| EV-to-Forward-EBIT | -2.42 | |||||
| EV-to-EBITDA | -3.67 | |||||
| EV-to-Forward-EBITDA | -0.06 | |||||
| EV-to-FCF | -4.21 | |||||
| Price-to-Net-Current-Asset-Value | 4.16 | |||||
| Price-to-Net-Cash | 4.28 | |||||
| Earnings Yield (Greenblatt) % | -27.86 | |||||
| FCF Yield % | -16.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:JSPR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jasper Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.74 | ||
| Beta | 4.03 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.61 | ||
| Volatility % | 105.06 | ||
| 14-Day RSI | 51.26 | ||
| 14-Day ATR ($) | 1.67875 | ||
| 20-Day SMA ($) | 22.2795 | ||
| 12-1 Month Momentum % | 380.98 | ||
| 52-Week Range ($) | 4 - 31.01 | ||
| Shares Outstanding (Mil) | 15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jasper Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jasper Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jasper Therapeutics Inc Frequently Asked Questions
What is Jasper Therapeutics Inc(JSPR)'s stock price today?
The current price of JSPR is $22.25. The 52 week high of JSPR is $31.01 and 52 week low is $4.00.
When is next earnings date of Jasper Therapeutics Inc(JSPR)?
The next earnings date of Jasper Therapeutics Inc(JSPR) is 2025-03-04 Est..
Does Jasper Therapeutics Inc(JSPR) pay dividends? If so, how much?
Jasper Therapeutics Inc(JSPR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers